PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.\', \'Department of Health Care Administration and Management, Kyushu University, Fukuoka, Japan.\', \'Department of Infectious Diseases, International University of Health and Welfare, Narita, Japan.\', \'Vaccine Medical Affairs, Pfizer Japan Inc., Tokyo, Japan.\', \'Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan.\', \'Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0256379
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34437567
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34437567>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34437567>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all